Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
A new study from UHN and The Hospital for Sick Children (SickKids) reveals a strategy to promote the production of insulin-producing cells – known as beta cells – in the lab. These cells could represent a new therapeutic approach with the potential to treat some types of diabetes.
Pancreatic beta cells help control the amount of sugar in our blood. They achieve this by sensing blood sugar and producing insulin to reduce blood sugar when it gets too high. In some types of diabetes, beta cells produce little to no insulin leading to sustained high blood sugar which can damage blood vessels, organs and nerves.
A novel treatment approach for diabetes that is in development involves the production of beta cells in the lab. These cells would then be transplanted into patients to help regulate their blood sugar and control their diabetes.
Human stem cells, which are capable of producing different types of cells in the body, are the starting point for producing these beta cells. Researchers can coax the stem cells into generating beta cells by turning on or off the activity of a select set of genes and proteins.
In their most recent publication, Dr. Cristina Nostro, a scientist at UHN's McEwen Stem Cell Institute, and her colleague, Dr. Tae-Hee Kim at SickKids, discovered that supportive tissues surrounding the developing pancreas and gut produce organ-specific signals required for proper development. The researchers then showed that these signals can be modulated in the petri dish to improve the stem cells' ability to produce pancreatic beta cells.
"We have identified a new strategy for promoting beta cell production," says Dr. Nostro. "This insight could help beta cell transplantation move one step closer to the clinic.
"In addition, our findings emphasize the importance of environmental cues in the development of different types of cells from stem cells."
This work was supported by the SickKids Foundation, the Cancer Research Society, the Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes of Health Research, the government of Ontario, and the Toronto General and Western Hospital Foundation. M Wilson holds a Tier 2 Canada Research Chair in Comparative Genomics.